NCT04663659

Brief Summary

The study includes patients over 18 years old who were hospitalized in our covid intensive care unit between March 16 and May 16, 2020. Retrospective records were examined by examining the electronic data files of the patients. Polymerase Chain Reaction (PCR) tests performed with nasopharyngeal swab taken from the person, which is the standard diagnostic method, and also the diagnosis of infection symptoms, risk factors and thoracic CT scans indicating pneumonia were diagnosed. Patients over 18 years of age with and without a medical history of DM in their history were identified and compared in 2 groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 11, 2020

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

2 months

First QC Date

December 10, 2020

Last Update Submit

December 10, 2020

Conditions

Covid19Diabetes Mellitus

Outcome Measures

Primary Outcomes (2)

  • Mortality

    Mortality rates of patients

    3 months

  • length of stay in intensive care

    The time between admission to intensive care unit and discharge

    3 months

Study Arms (2)

diabetic group

Patients over the age of 18 with diabetes mellitus in intensive care unit

Other: no intervention

non-diabetic group

Patients over the age of 18 without diabetes mellitus in intensive care unit

Other: no intervention

Interventions

no interventionOTHER

no intervention

diabetic groupnon-diabetic group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 18 years of age with and without a medical history of DM in their history will be identified and compared in 2 groups

You may qualify if:

  • All patients over 18 years of age

You may not qualify if:

  • Patients under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SisliHamidiye Etfal Education and Training Hospital

Istanbul, 34771, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Diabetes Mellitus

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Nermin Balta Basi

    Sisli Hamidiye Etfal Education and Training Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

December 10, 2020

First Posted

December 11, 2020

Study Start

March 15, 2020

Primary Completion

May 15, 2020

Study Completion

May 15, 2020

Last Updated

December 14, 2020

Record last verified: 2020-12

Locations

TU(1)